<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES:There is suggestive but sparse evidence that <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> is associated with colorectal <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the association of serum <z:chebi fb="23" ids="18059">lipid</z:chebi> and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> concentrations with the prevalence of colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath>.METHODS:Cross-sectional study of 19,281 consecutive participants aged 40-79 years undergoing screening colonoscopy at the Center for Health Promotion of the Samsung Medical Center in Korea from January 2006 to June 2009.RESULTS:We identified 5,958 participants with colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> (30.9%), including 5,504 (28.5%) with non-advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 454 (2.4%) with advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>The adjusted relative prevalence ratios (aRPRs) comparing the fourth with the first quartiles of serum <z:chebi fb="4" ids="17855">triglycerides</z:chebi> were 1.35 (95% confidence interval (CI) 1.20-1.52; P trend&lt;0.001) for non-advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 1.45 (95% CI 1.02-2.06; P trend=0.005) for advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Higher levels of <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A-1 (ApoA-1) were significantly associated with 12% (Q4 vs. Q1 aRPR 1.12; 95% CI 1.00-1.26; P trend=0.049) and 17% (Q4 vs. Q1 aRPR 1.17; 95% CI 1.04-1.31; P trend=0.004) higher prevalence of non-advanced <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>There was also a non-significant association between higher levels of <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) cholesterol (Q4 vs. Q1 aRPR 1.22; 95% CI 0.91-1.66; P trend= 0.12) and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B (ApoB) (Q4 vs. Q1 aRPR 1.32; 95% CI 0.94-1.83; P trend=0.07) with higher prevalence of advanced <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>There was no association between total cholesterol levels with colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath>.CONCLUSIONS:In this large cross-sectional study, higher levels of serum <z:chebi fb="4" ids="17855">triglycerides</z:chebi> were significantly associated with an increasing prevalence of both non-advanced and advanced colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath>, while higher levels of ApoA-1 and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> were significantly associated with an increasing prevalence of non-advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath>.Am J Gastroenterol advance online publication, 2 April 2013; doi:10.1038/ajg.2013.64 </plain></SENT>
</text></document>